167 related articles for article (PubMed ID: 31932380)
1. Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective
Reitzel RA; Rosenblatt J; Gerges BZ; Vargas-Cruz N; Raad II
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932380
[No Abstract] [Full Text] [Related]
2. Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol.
Raad I; Chaftari AM; Zakhour R; Jordan M; Al Hamal Z; Jiang Y; Yousif A; Garoge K; Mulanovich V; Viola GM; Kanj S; Pravinkumar E; Rosenblatt J; Hachem R
Antimicrob Agents Chemother; 2016 Jun; 60(6):3426-32. PubMed ID: 27001822
[TBL] [Abstract][Full Text] [Related]
3. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for
Vargas-Cruz N; Reitzel RA; Rosenblatt J; Chaftari AM; Wilson Dib R; Hachem R; Kontoyiannis DP; Raad II
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036689
[No Abstract] [Full Text] [Related]
4. EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence
Colombari B; Alfano G; Gamberini C; Cappelli G; Blasi E
Microbiol Spectr; 2021 Dec; 9(3):e0104721. PubMed ID: 34787464
[TBL] [Abstract][Full Text] [Related]
5. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm.
Raad I; Hanna H; Dvorak T; Chaiban G; Hachem R
Antimicrob Agents Chemother; 2007 Jan; 51(1):78-83. PubMed ID: 17074799
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties.
Piątkowska E; Paleczny J; Dydak K; Letachowicz K
PLoS One; 2021; 16(10):e0258148. PubMed ID: 34618850
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections.
Reitzel RA; Rosenblatt J; Hirsh-Ginsberg C; Murray K; Chaftari AM; Hachem R; Raad I
Antimicrob Agents Chemother; 2016 Sep; 60(9):5175-81. PubMed ID: 27297475
[TBL] [Abstract][Full Text] [Related]
8. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
Chu HP; Brind J; Tomar R; Hill S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
Luther MK; Mermel LA; LaPlante KL
J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
[TBL] [Abstract][Full Text] [Related]
10. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
11. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
Neusser MA; Bobe I; Hammermeister A; Wittmann U
Br J Nurs; 2021 Jul; 30(14):S24-S32. PubMed ID: 34288746
[TBL] [Abstract][Full Text] [Related]
12. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
13. Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?
Toulet D; Debarre C; Imbert C
J Antimicrob Chemother; 2012 Feb; 67(2):430-2. PubMed ID: 22081268
[TBL] [Abstract][Full Text] [Related]
14. Chelator-based catheter lock solutions in eradicating organisms in biofilm.
Raad I; Rosenblatt J; Reitzel R; Jiang Y; Dvorak T; Hachem R
Antimicrob Agents Chemother; 2013 Jan; 57(1):586-8. PubMed ID: 23070163
[TBL] [Abstract][Full Text] [Related]
15. Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.
Fontseré N; Cardozo C; Donate J; Soriano A; Muros M; Pons M; Mensa J; Campistol JM; Navarro-González JF; Maduell F
Antimicrob Agents Chemother; 2014 Jul; 58(7):4180-4. PubMed ID: 24820084
[TBL] [Abstract][Full Text] [Related]
16. International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections.
Hachem R; Kanj S; Hamerschlak N; Saad H; Assir FF; Mori N; Jiang Y; Ghaly F; Chaftari AM; Raad II
Expert Rev Med Devices; 2018 Jun; 15(6):461-466. PubMed ID: 29927699
[TBL] [Abstract][Full Text] [Related]
17. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
[TBL] [Abstract][Full Text] [Related]
18. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
Zwiech R; Adelt M; Chrul S
Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms.
Passerini de Rossi B; Feldman L; Pineda MS; Vay C; Franco M
J Med Microbiol; 2012 Sep; 61(Pt 9):1248-1253. PubMed ID: 22580911
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
